Asia Pacific Hemp Source CBD Market Size & Outlook, 2026-2034
Asia Pacific Hemp Source CBD Market Insights
- Deep Market Insights analysis indicates that the Asia Pacific Hemp Source CBD Market size, which was USD 680.21 Million in 2025, is projected to attain USD 1768.99 Million by 2034.
- The market is expected to register a CAGR of 11.23% over the period 2026–2034.
- In 2025, Hemp-derived CBD Distillate emerged as the dominant Type based on market size.
- Hemp-derived CBD Terpenes is projected to register the fastest growth, positioning it as the most attractive Type segment over the forecast horizon.
![Asia Pacific Hemp Source CBD Market Size, Share & Growth Analysis By [2034]](https://deepmarketinsights.com/uploads/charts/hemp-source-cbd-market-asia-pacific--1351.png)
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- Asia Pacific held 23.29% share of the global Hemp Source CBD Market size in 2025.
- United States is expected to remain the largest contributor to the global market size by 2034.
- By 2034, Singapore is anticipated to record the highest growth in Asia Pacific, with the market size expected to reach USD 40.98 Million.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 680.21 Million |
| Market Size In 2034 | USD 1768.99 Million |
| Largest segment | Hemp-derived CBD Distillate |
| Units | Revenue in USD Million |
| CAGR | 11.23% (2026-2034) |
| Segmnetation Covered | |
| Asia Pacific |
|
| Type |
|
| Application |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Asia Pacific Hemp Source CBD Market Country 2026-2034 (USD Million)
| Asia Pacific | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China | XX.x | XX.x | XX.x | 260.59 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| India | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Japan | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Korea | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Taiwan | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Australia | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Singapore | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| South East Asia | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Asia Pacific Hemp Source CBD Market Type 2026-2034 (USD Million)
| Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hemp-derived CBD Distillate | XX.x | XX.x | XX.x | 321.2 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Hemp-derived CBD Isolate | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Hemp-derived CBD Terpenes | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Asia Pacific Hemp Source CBD Market Application 2026-2034 (USD Million)
| Application | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Personal Care and Cosmetics | XX.x | XX.x | XX.x | 274.8 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Food and Beverages | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Nutraceuticals | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Others | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.